Add to ORKGAseptic meningitis is a rare and aggressive complication of rheumatoid arthritis (RA), usually histologically characterised by rheumatoid nodules and lymphocytic aggregates in leptomeninges. The aim of this study was to describe the clinical onset and evolution of aseptic meningitis occurring during anti-TNF-alpha (TNF-α) therapy
Rheumatoid meningitis is a rare and very serious extra-articular manifestation of rheumatoid arthrit...
Targeting tumor necrosis factor alpha (TNF-alpha) has offered an additional therapeutic strategy aga...
Central nervous system (CNS) involvement is quite unusual in patients with rheumatoid arthritis (RA)...
Background \ud We report a case of a 53 year old lady recently commenced on etanercept, an anti-TNF ...
To report the clinical, radiological and neuropathological findings of a patient with rheumatoid men...
We report a 65-year-old man who had repetitive seizures 6 months after receiving etanercept, methotr...
Central nervous system (CNS) involvement in rheumatoid arthritis (RA) is uncommon, and most of the t...
ABSTRACT. Tumor necrosis factor-a (TNF-a) inhibition, used in the treatment of rheumatoid arthritis ...
Rheumatoid arthritis is well known for multiple extra-articular manifestations. Here, we present a c...
International audienceOBJECTIVE: To describe cases of development of pulmonary nodulosis or aseptic ...
WOS: 000250841700014PubMed ID: 17622534It has been well known that anti-TNF drugs might increase lym...
Various dermatological conditions have been reported during tumor necrosis factor (TNF)-alpha-blocki...
Abstract Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remis...
We present a case of a 60-year-old Caucasian woman with a 23-year history of rheumatoid arthritis, w...
Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheum...
Rheumatoid meningitis is a rare and very serious extra-articular manifestation of rheumatoid arthrit...
Targeting tumor necrosis factor alpha (TNF-alpha) has offered an additional therapeutic strategy aga...
Central nervous system (CNS) involvement is quite unusual in patients with rheumatoid arthritis (RA)...
Background \ud We report a case of a 53 year old lady recently commenced on etanercept, an anti-TNF ...
To report the clinical, radiological and neuropathological findings of a patient with rheumatoid men...
We report a 65-year-old man who had repetitive seizures 6 months after receiving etanercept, methotr...
Central nervous system (CNS) involvement in rheumatoid arthritis (RA) is uncommon, and most of the t...
ABSTRACT. Tumor necrosis factor-a (TNF-a) inhibition, used in the treatment of rheumatoid arthritis ...
Rheumatoid arthritis is well known for multiple extra-articular manifestations. Here, we present a c...
International audienceOBJECTIVE: To describe cases of development of pulmonary nodulosis or aseptic ...
WOS: 000250841700014PubMed ID: 17622534It has been well known that anti-TNF drugs might increase lym...
Various dermatological conditions have been reported during tumor necrosis factor (TNF)-alpha-blocki...
Abstract Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remis...
We present a case of a 60-year-old Caucasian woman with a 23-year history of rheumatoid arthritis, w...
Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheum...
Rheumatoid meningitis is a rare and very serious extra-articular manifestation of rheumatoid arthrit...
Targeting tumor necrosis factor alpha (TNF-alpha) has offered an additional therapeutic strategy aga...
Central nervous system (CNS) involvement is quite unusual in patients with rheumatoid arthritis (RA)...